After the discovery of cisplatin, many metal compounds were investigated for the therapy of
diseases, especially cancer. The high therapeutic potential of metal-based compounds is …

Approximately 100 million people worldwide are affected by M. Tuberculosis (Mtb), a
contagious disease which causes death in humans and is considered to be quite deadly …

Injections of highly cytotoxic or immunomodulating drugs directly into the inoperable tumor is
a procedure that is increasingly applied in the clinic and uses established Pt-based drugs. It …

Organometallic metal (arene) anticancer agents were believed to confer low selectivity for
potential cellular targets. However, the ruthenium (arene) pyridinecarbothioamide (plecstatin …

Head and neck squamous cell carcinomas (HNSCCs) are a complex group of malignancies
that affect different body sites pertaining to the oral cavity, pharynx and larynx. Current …

A new series of Zr (IV), V (IV), Ru (III), and Cd (II) complexes with the ligand N‐((5‐hydroxy‐4‐
oxo‐4H‐pyran‐3‐yl) methylene)‐2‐(p‐tolylamino) acetohydrazide (H2L) have been …

In this work, six new mixed-ligand Cu (II), Co (II), Mn (II) complexes with 5-phenyltetrazole
(HL) and polypyridine ligands (phen–1, 10-phenanthroline, dmbipy–2, 2′-bi-4-picoline …

Arene–ruthenium (II) complexes with carbothioamidopyrazoles at the C-2 and C-5 positions
have been recognized as chemotherapeutic agent alternatives to cisplatin and its oxaliplatin …

In this review we have showcased the preclinical development of original amphiphilic
nanomaterials designed for ruthenium-based anticancer treatments, to be placed within the …

The past decade has seen tremendous demand for the production of new materials based
on metal-containing macromolecules. Many research groups have dedicated their time and …